GenMark Diagnostic Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

GenMark Diagnostics is a molecular diagnostics company focused on developing and commercializing its sensor detection technology. The Company’s electrochemical technology enables the detection of up to 72 distinct biomarkers in a single sample. Its XT-8 System has received 510(k) clearance from the United States Food and Drug Administration (FDA) and is designed to support a range of molecular diagnostic tests with a compact workstation and self-contained, disposable test cartridges. Within 30 m

Company Highlights
Year Founded

2010

icon-altStatus

Acquired

icon-altEmployees

441

Location (HQ)

USA

Since Last Funding

4 years 6 months

Monthly Website Visitors

214

icon-altTotal Investment Amt

$100M

Last Funding Round

Post Ipo Equity

icon-altYoY Headcount Growth

-4.96%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Health Care

Biotechnology

Medical Equipment Manufacturing

Medical

Health Diagnostics